BBO
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT • NASDAQ
BridgeBio Oncology Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Eli Wallace, with a market cap of $708.7M.
Market Cap$708.7M
CEOEli Wallace
CountryUnited States of America
Next EarningsMay 26, 2026 · in a monthQ1 2026
Financials
BBO
BridgeBio Oncology Therapeutics, Inc. Common Stock FAQ
Common questions about BridgeBio Oncology Therapeutics, Inc. Common Stock
BridgeBio Oncology Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 26, 2026.